Neuro-Bio's Series A Round

Neuro-Bio raised a round of funding on March 24, 2017. Investors include Kairos Ventures.

Neuro-Bio is an early stage biopharmaceutical company focusing on neurodegenerative diseases. The company is developing a diagnostic tool for early detection of Alzheimer's and discovering new drugs t…

Articles about Neuro-Bio's Series A Round: